Ditchcarbon
  • Contact
  1. Organizations
  2. Athersys, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Athersys, Inc. Sustainability Profile

Company website

Athersys, Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative therapies for critical medical conditions. Founded in 1998, Athersys has made significant strides in the field of regenerative medicine, particularly through its proprietary MultiStem® cell therapy platform. This unique technology harnesses the power of stem cells to address various diseases, including neurological disorders and cardiovascular conditions. With a strong presence in the US and collaborations across Europe and Asia, Athersys is well-positioned in the competitive biotech landscape. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market reach. Athersys continues to advance its mission of transforming patient care through cutting-edge science and a commitment to improving health outcomes.

DitchCarbon Score

How does Athersys, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Athersys, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Athersys, Inc.'s reported carbon emissions

Athersys, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Athersys may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. As the industry increasingly prioritises sustainability, Athersys may need to consider developing measurable climate commitments to align with broader environmental goals.

How Carbon Intensive is Athersys, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Athersys, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Athersys, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Athersys, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Athersys, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Athersys, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Athersys, Inc.'s Emissions with Industry Peers

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Vericel Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Smart Surgical, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Orthofix

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 month ago

EBIR

ES
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

BioTissue Holdings Inc.

US
•
Research and development services (73)
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251209.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy